We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Greif
GEF
$5.04B
| $5.17M | ﹤0.01% |
77,126
-12,219
| -14% | -$823K |
|
1852
Corcept Therapeutics
CORT
$12B
| $5.16M | ﹤0.01% |
254,058
-8,986
| -3% | -$225K |
|
1853
Helios Technologies
HLIO
$2.76B
| $5.16M | ﹤0.01% |
94,748
-14,621
| -13% | -$788K |
|
1854
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $5.15M | ﹤0.01% |
+22,098
| New | +$5.14M |
|
|
DOOR
1855
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $5.13M | ﹤0.01% |
63,646
-2,675
| -4% | -$198K |
|
1856
LeMaitre Vascular
LMAT
$1.86B
| $5.1M | ﹤0.01% |
110,780
+1,506
| +1% | +$70.5K |
|
1857
Hilltop Holdings
HTH
$2.24B
| $5.08M | ﹤0.01% |
169,423
-25,524
| -13% | -$726K |
|
1858
Upwork
UPWK
$1.19B
| $5.08M | ﹤0.01% |
486,902
-54,626
| -10% | -$674K |
|
1859
Legend Biotech
LEGN
$4.01B
| $5.07M | ﹤0.01% |
101,571
-1,700
| -2% | -$82.4K |
|
1860
Interparfums
IPAR
$3.94B
| $5.04M | ﹤0.01% |
52,242
-1,694
| -3% | -$147K |
|
1861
XPEL
XPEL
$1.38B
| $5.04M | ﹤0.01% |
83,882
-67,665
| -45% | -$4.32M |
|
|
NTZG
1862
DELISTED
Nuveen Global Net Zero Transition ETF
NTZG
| $5.04M | ﹤0.01% |
195,705
| – | – |
|
1863
Lakeland Financial Corp
LKFN
$1.53B
| $5.03M | ﹤0.01% |
68,963
-4,459
| -6% | -$341K |
|
1864
Maravai LifeSciences
MRVI
$919M
| $5.03M | ﹤0.01% |
351,163
+2,067
| +0.6% | +$32.5K |
|
1865
REX American Resources
REX
$1.41B
| $5.01M | ﹤0.01% |
107,026
-15,212
| -12% | -$229K |
|
|
KREF
1866
KKR Real Estate Finance Trust
KREF
$499M
| $5M | ﹤0.01% |
358,401
-112,231
| -24% | -$1.83M |
|
|
CVSA
1867
Covista Inc
CVSA
$4.8B
| $4.99M | ﹤0.01% |
140,669
-28,172
| -17% | -$1.1M |
|
1868
Beyond Meat
BYND
$277M
| $4.99M | ﹤0.01% |
405,420
+211,303
| +109% | +$2.94M |
|
1869
Urban Edge Properties
UE
$2.73B
| $4.97M | ﹤0.01% |
352,958
-55,805
| -14% | -$801K |
|
|
ROCC
1870
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $4.96M | ﹤0.01% |
131,176
+72,167
| +122% | +$2.86M |
|
1871
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $4.95M | ﹤0.01% |
12,950
+8,450
| +188% | +$3.25M |
|
1872
AnaptysBio
ANAB
$1.68B
| $4.95M | ﹤0.01% |
159,694
-68,088
| -30% | -$1.92M |
|
|
NAPA
1873
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $4.94M | ﹤0.01% |
298,363
-172,150
| -37% | -$2.65M |
|
1874
C3.ai
AI
$1.59B
| $4.94M | ﹤0.01% |
441,611
+203,159
| +85% | +$2.54M |
|
1875
SiTime
SITM
$21.8B
| $4.93M | ﹤0.01% |
48,538
-5,651
| -10% | -$534K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.